GAMCO Investors’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-7,000
Closed -$224K 926
2022
Q2
$224K Hold
7,000
﹤0.01% 825
2022
Q1
$292K Hold
7,000
﹤0.01% 820
2021
Q4
$312K Hold
7,000
﹤0.01% 814
2021
Q3
$350K Hold
7,000
﹤0.01% 792
2021
Q2
$375K Buy
7,000
+2,000
+40% +$100K ﹤0.01% 792
2021
Q1
$229K Hold
5,000
﹤0.01% 859
2020
Q4
$239K Hold
5,000
﹤0.01% 825
2020
Q3
$224K Buy
+5,000
New +$211K ﹤0.01% 812

Other funds holding ELAT

GAMCO Investors's ELAT Position: Q3 2022 in Review

GAMCO Investors sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q3 2022, closing a stake of 7,000 shares — an estimated $224K sold.

GAMCO Investors first reported a position in ELAT in Q3 2020 and held it in 8 quarters. The position peaked at $375K in Q2 2021. 31 funds tracked by Wall St. Rank hold ELAT as of Q3 2022.

  • GAMCO Investors reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q3 2022 after selling out during the quarter.
  • GAMCO Investors sold 7,000 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q3 2022, an estimated $224K.
  • GAMCO Investors first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q3 2020 and held it in 8 quarters.
  • GAMCO Investors's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $375K in Q2 2021.
  • 31 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q3 2022.

Based on GAMCO Investors's 13F filing for Q3 2022, filed 10 Nov 2022.